David M Kurtz

29PUBLICATIONS
175CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

|Dec 12, 2025
Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Steven Wang, Marcel Nijland, Leonie Strobbe

|Nov 25, 2025
Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine.

Hitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol

|Nov 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Mark P Hamilton, Nick Phillips, Troy Noordenbos

|Aug 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.

Mark Roschewski, David M Kurtz, Jason R Westin

|Aug 07, 2025
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial.

Paolo Strati, Lei Feng, Jason R Westin

Pageof 5

Frequent Collaborators

24 joint publications

Ash Alizadeh

12 joint publications

Maximilian Diehn

9 joint publications

Stefan K Alig

5 joint publications

Jacob J Chabon